뇌실외배액(EVD) 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 환자 유형별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

External Ventricular Drain Market Summary

The global external ventricular drain market size was estimated at USD 1.61 billion in 2025 and is projected to reach USD 3.26 billion by 2033, growing at a CAGR of 9.29% from 2026 to 2033. The rising incidence of traumatic brain injuries, stroke, hydrocephalus, and intracranial hemorrhage worldwide primarily drives the market growth.

The growing demand for effective intracranial pressure monitoring and cerebrospinal fluid management in critical care settings is driving increased device adoption. Advancements in infection-resistant catheter technologies and integrated monitoring systems are further supporting the growth of the external ventricular drain industry. In addition, expanding neurocritical care infrastructure and growing healthcare investments across emerging economies are accelerating global market expansion.

The rising prevalence of neurological disorders is a major driver of growth in the external ventricular drain market. Increasing cases of conditions such as traumatic brain injury, stroke, intracerebral hemorrhage, hydrocephalus, and brain tumors have significantly elevated the need for effective intracranial pressure management and cerebrospinal fluid drainage. Aging populations, lifestyle-related risk factors like hypertension, and higher survival rates following neurological emergencies are further contributing to the growing patient pool. As a result, the demand for advanced External Ventricular Drain (EVD) systems in neurocritical care and emergency settings continues to expand globally.

The growing incidence of road accidents and head trauma is a significant driver for the external ventricular drain market growth. Traumatic brain injuries resulting from motor vehicle collisions, falls, and sports-related accidents often lead to elevated intracranial pressure and intracranial bleeding, requiring immediate cerebrospinal fluid drainage. The increasing number of emergency admissions to trauma centers and intensive care units has amplified the demand for EVD systems as a critical life-saving intervention. Consequently, the rising global burden of head injuries continues to support market growth.

Thus, the increasing burden of neurological disorders and rising cases of head trauma are driving higher demand for external ventricular drain systems. The growing need for rapid intracranial pressure management in emergencies and neurocritical care settings continues to support steady market expansion.

Global External Ventricular Drain Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global external ventricular drain market report based on product, patient type, end use, and region:

• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Traumatic Brain Injury
• Subarachnoid Hemorrhage
• Intracerebral Hemorrhage
• Other Non-traumatic Hydrocephalus Conditions
• Patient Type Outlook (Revenue, USD Million, 2021 - 2033)
• Adult
• Pediatric
• End Use Outlook (Revenue, USD Million; 2021 - 2033)
• Hospitals
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Sweden
  • Denmark
  • Norway
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Application
  • 1.1.2. Patient Type
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Methodology & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. External Ventricular Drain Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising prevalence of neurological disorders
    • 3.2.1.2. Growing incidence of road accidents & head trauma
    • 3.2.1.3. Increase in neurosurgical & ICU procedures
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High risk of infections (EVD-associated infections)
    • 3.2.2.2. High procedure & hospitalization costs
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Development of infection-resistant EVD systems
    • 3.2.3.2. Integration with advanced ICP monitoring technologies
    • 3.2.3.3. Expansion in emerging markets
    • 3.2.3.4. Technological advancements
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Catheter blockage & device malfunction
    • 3.2.4.2. Stringent regulatory & compliance requirements
    • 3.2.4.3. Competition from alternative CSF management solutions
• 3.3. External Ventricular Drain Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. External Ventricular Drain Market: Application Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global External Ventricular Drain Market: Application Movement Analysis, 2025 & 2033 (USD Million)
• 4.3. Global External Ventricular Drain Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.3.1. Traumatic Brain Injury
    • 4.3.1.1. Traumatic brain injury market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Subarachnoid Hemorrhage
    • 4.3.2.1. Subarachnoid hemorrhage market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.3.3. Intracerebral Hemorrhage
    • 4.3.3.1. Intracerebral hemorrhage market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.3.4. Other Non-traumatic Hydrocephalus Conditions
    • 4.3.4.1. Other non-traumatic hydrocephalus conditions market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. External Ventricular Drain Market: Patient Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global External Ventricular Drain Market: Patient Type Movement Analysis, 2025 & 2033 (USD Million)
• 5.3. Global External Ventricular Drain Market Size & Trend Analysis, by Patient Type, 2021 to 2033 (USD Million)
  • 5.3.1. Adult
    • 5.3.1.1. Adult market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.2. Pediatric
    • 5.3.2.1. Pediatric market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. External Ventricular Drain Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global External Ventricular Drain Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
• 6.3. Global External Ventricular Drain Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
  • 6.3.1. Hospitals
    • 6.3.1.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Others
    • 6.3.2.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. External Ventricular Drain Market: Regional Estimates & Trend Analysis by Application, Patient Type, and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. North America external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Competitive scenario
    • 7.3.2.3. Regulatory framework
    • 7.3.2.4. Reimbursement scenario
    • 7.3.2.5. U.S. external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Competitive scenario
    • 7.3.3.3. Regulatory framework
    • 7.3.3.4. Reimbursement scenario
    • 7.3.3.5. Canada external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Competitive scenario
    • 7.3.4.3. Regulatory framework
    • 7.3.4.4. Reimbursement scenario
    • 7.3.4.5. Mexico external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Reimbursement scenario
    • 7.4.2.5. UK external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Reimbursement scenario
    • 7.4.3.5. Germany external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. Reimbursement scenario
    • 7.4.4.5. France external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Competitive scenario
    • 7.4.5.3. Regulatory framework
    • 7.4.5.4. Reimbursement scenario
    • 7.4.5.5. Italy external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Competitive scenario
    • 7.4.6.3. Regulatory framework
    • 7.4.6.4. Reimbursement scenario
    • 7.4.6.5. Spain external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Competitive scenario
    • 7.4.7.3. Regulatory framework
    • 7.4.7.4. Reimbursement scenario
    • 7.4.7.5. Sweden external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Competitive scenario
    • 7.4.8.3. Regulatory framework
    • 7.4.8.4. Reimbursement scenario
    • 7.4.8.5. Denmark external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Competitive scenario
    • 7.4.9.3. Regulatory framework
    • 7.4.9.4. Reimbursement scenario
    • 7.4.9.5. Norway external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. China external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Japan
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Japan external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. India external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Reimbursement scenario
    • 7.5.5.5. South Korea external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. Australia external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. Thailand external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Brazil external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Argentina external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. Middle East and Africa
  • 7.7.1. Middle East and Africa external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. South Africa external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Saudi Arabia external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. UAE external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Kuwait external ventricular drain market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis, 2025
• 8.4. Company Heat Map Analysis
• 8.5. Strategy Mapping
  • 8.5.1. Expansion
  • 8.5.2. Mergers & Acquisition
  • 8.5.3. Partnerships & Collaborations
  • 8.5.4. New Product Launches
  • 8.5.5. Research And Development
  • 8.5.6. Company Profiles
  • 8.5.7. Spiegelberg GmbH & Co. KG (Luciole Medical AG)
    • 8.5.7.1. Company overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Medtronic
    • 8.5.8.1. Company overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Sophysa
    • 8.5.9.1. Company overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Natus Medical Incorporated
    • 8.5.10.1. Company overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. Neuromedex GmbH
    • 8.5.11.1. Company overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product Benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. Integra LifeSciences
    • 8.5.12.1. Company overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product Benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. Moller Medical GmbH ( Centrotec Sustainable AG)
    • 8.5.13.1. Company overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product Benchmarking
    • 8.5.13.4. Strategic initiatives
  • 8.5.14. B. Braun SE
    • 8.5.14.1. Company overview
    • 8.5.14.2. Financial performance
    • 8.5.14.3. Product Benchmarking
    • 8.5.14.4. Strategic initiatives
  • 8.5.15. Fuji Systems
    • 8.5.15.1. Company overview
    • 8.5.15.2. Financial performance
    • 8.5.15.3. Product Benchmarking
    • 8.5.15.4. Strategic initiatives